Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Vertex Offers Cystic Fibrosis Patients A Chance To Breathe Easier

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

While most attention has been on Vertex Pharmaceuticals' hepatitis C drug telaprevir, which is widely expected to gain FDA approval in May, the company has also been steadily progressing on its investigational cystic fibrosis agents, and it may have lined up another home run.

You may also be interested in...

Myeloma Foundation Uses Patient Connections To Help Speed Drug Trials

Bolstered by a huge patient database, the Multiple Myeloma Research Consortium is helping to speed trials of new therapies, including some of the most talked about investigational drugs in the disease space, like carfilzomib and pomalidomide.

Breath Of Fresh Air For Cystic Fibrosis Drug Pipeline

The outlook for cystic fibrosis drug development now is "a very different story than even five years ago," according to Cystic Fibrosis Foundation President Robert Beall.

IPO Update: Patheon Public Once Again, Audentes To Move Into The Clinic

Two companies in the biopharma space began trading publicly this week, one to pay off debt, the other to fund an early-stage pipeline.


Latest News
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts